BLS vs RHY

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

RHY

RHYTHM BIO FPO [RHY]

45LOW

Score Breakdown

BLS RHY
Technical
49
38
Catalyst
55
45
Sentiment
50
50
Fundamental
96
34
Momentum
84
46
Risk Gate
50
50

Key Metrics

BLS Metric RHY
$193.2MMarket Cap$30.4M
218KAvg Volume (20d)229K
+0.0%Short InterestN/A
$1.10052-Week High$0.280
$0.33052-Week Low$0.052
+1.8%Daily Change-5.9%
$0.855Reference Price$0.080
+66.1%ROE-190.1%
+18.7%Profit MarginN/A

Active Signals

BLS Signals

MACD momentum is losing steam
Drifting lower — down 8.1% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Low P/S ratio (4.0x)
Strong revenue growth (+150%)
Piotroski F-Score strong (8/9, low-confidence approx)

RHY Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Trading below both moving averages — the trend is working against this one
Above-average volume (1.5x) on a red day — sellers in control
Broke below 20-day support — that's a level the market was defending, and it just gave way
Drifting lower — down 5.9% over the last 5 days
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers

Ask Scout AI to compare BLS and RHY in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs VIT →BMT vs ECS →BMT vs EIQ →BMT vs GSS →BMT vs HLS →
BLS Full Analysis → RHY Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).